Navigation Links
DuPont Named to Biofuels Digest 2010 “Transformative Technologies 303

DuPont Collaborations with Key Partners Recognized

Wilmington, Del. (Vocus) June 22, 2010 -- All three DuPont biofuels collaborations received top honors in the 2010 “Transformative Technologies 30” survey, conducted by Biofuels Digest. The DuPont Danisco Cellulosic Ethanol (DDCE) joint venture and the DuPont partnership with Bio Architecture Lab (BAL) to develop macroalgae to butanol capabilities placed first, while the Butamax™ Advanced Biofuels joint venture placed second in their respective categories. The full results can be found here.

“DuPont is paving a new road for transportation fuels by delivering a portfolio of new biofuels technologies,” said DuPont Applied BioSciences President Craig F. Binetti. “Each venture incorporates game-changing science and tailored business models that maximize our ability to deliver large volumes of biofuels to a global population that is increasingly more interested in alternatives to oil.”

DDCE garnered the top ranking with 27.5 percent of the vote in the category: Transformative Technology: cellulosic ethanol – U.S. companies. The 50/50 joint venture of DuPont and Danisco has made rapid progress since it was established in 2008. DDCE has started up a 250,000-gallon demonstration-scale biorefinery in Tennessee and brought the cost of production below $2 per gallon. DDCE expects to announce its first commercial plans this fall.

“Cellulosic ethanol is ready for deployment,” Binetti said. With 28.6 percent of the vote in the biobutanol platforms category, the Butamax™ Advanced Biofuels joint venture was voted a clear leader in the development of biobutanol technologies.

“The strategic plan for Butamax™ is to give biorefineries the option to convert from ethanol to biobutanol in the future. The joint venture has started some preliminarily exploratory discussions with ethanol producers in the United States and Brazil,” Binetti said.

The U.S. Department of Energy Advanced Research Projects Agency – Energy (ARPA-E) awarded funding to DuPont and its partner BAL last fall to develop a process to convert macroalgae to biobutanol. The DuPont-BAL partnership placed first, garnering 52.2 percent of the vote in the category: Transformative Technology: macro algae platforms. “Macroalgae to biobutanol could reduce greenhouse gas emissions by more than 90 percent when compared to petroleum and diversify feedstock routes for advanced biofuels,” Binetti said.

Biofuels Digest readers submitted more than 48,000 votes from 3,500 ballots during the three-week voting process. The readers chose between transformative bioenergy technologies at more than 250 companies, universities and national laboratories, including 100 organizations that received write-in votes.

DuPont ( is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 90 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

Forward-Looking Statements: This news release contains forward-looking statements based on management’s current expectations, estimates and projections. The company does not undertake to update any forward-looking statements as a result of future developments or new information. All statements that address expectations or projections about the future, including statements about the company’s strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like “expects,” “anticipates,” “plans,” “intends,” “projects,” “indicates,” and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in DuPont’s filings with the Securities and Exchange Commission, particularly its latest annual report on Form 10-K, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions of countries in which the company does business; competitive pressures; successful integration of structural changes, including acquisitions, divestitures and alliances; research and development of new products, including regulatory approval and market acceptance, and seasonality of sales of agricultural products.

Butamax™ is a trademark of Butamax™ Advanced Biofuels LLC, a BP-DuPont joint venture

# # #

Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. DuPont Leaders Brief Investors on Agriculture Businesses
2. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
3. DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration
4. DuPont Named Among Top Biotechnology Employers by Science Magazine
5. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
6. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
7. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
8. DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
9. DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum
10. DuPont and Precision BioSciences Collaborate to Accelerate Crop Product Development
11. Research Confirms Better Oil from New DuPont High Oleic Soybean Trait
Post Your Comments:
Related Image:
DuPont Named to Biofuels Digest 2010 “Transformative Technologies 303
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and CEO of Neurocrine Biosciences, ... Healthcare Conference in New York . ... to visit the website approximately 5 minutes prior to ... A replay of the presentation will be available on ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... company uBiome, were featured on AngelList early in their initial angel funding process. ... AngelList syndicate for individuals looking to make early stage investments in the microbiome ...
(Date:11/24/2015)... Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or ... financial results for the quarter ended September 30, ... Canadian dollars and presented under International Financial Reporting ... ," said Andrew Rae , President ... iCo-008 are not only value enriching for this ...
(Date:11/24/2015)... , November 24, 2015 ... market research report "Oligonucleotide Synthesis Market by Product & ... Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & ... by MarketsandMarkets, the market is expected to reach USD ... 2015, at a CAGR of 10.1% during the forecast ...
Breaking Biology Technology:
(Date:11/17/2015)... Paris from 17 th ... Paris from 17 th until 19 th ... leader, has invented the first combined scanner in the world ... scanning surface. Until now two different scanners were required: one ... both on the same surface. This innovation is an ...
(Date:11/16/2015)... JOSE, Calif. , Nov 16, 2015 /PRNewswire/ ... developer of human interface solutions, today announced expansion ... Synaptics TouchView ™ touch controller and display ... architectural revolution of smartphones. These new TDDI products ... include TD4100 (HD resolution), TD4302 (WQHD resolution), and ...
(Date:11/11/2015)... MINNETONKA, Minn. , Nov. 11, 2015   MedNet ... the entire spectrum of clinical research, is pleased to announce ... Partnerships in Clinical Trials (PCT) event, to be held ... will be able to view live demonstrations of ... platform, and learn how iMedNet has been able ...
Breaking Biology News(10 mins):